Related Experiment Video
Updated: Jan 17, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
CX3CL1: a key switch of cell death immunogenicity.
Robin Demuynck1, Faye Naessens1, Dmitri V Krysko1
1Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium.
Fractalkine (CX3CL1) has dual roles in cancer, promoting or suppressing tumors. CX3CL1-based therapies, especially with immune checkpoint inhibitors, show promise for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Fractalkine (CX3CL1) is a chemokine with a dual role in cancer biology.
- It acts via its receptor CX3CR1, influencing tumor progression and immune responses.
Purpose of the Study:
- To elucidate the multifaceted roles of CX3CL1 in cancer.
- To explore the therapeutic potential of CX3CL1-based strategies.
Main Methods:
- Review of existing literature on CX3CL1 function in cancer.
- Analysis of CX3CL1's interactions with immune cells and tumor cells.
Main Results:
- CX3CL1 can promote tumor growth by recruiting immunosuppressive cells.
- Conversely, it can enhance anti-tumor immunity by attracting cytotoxic immune cells.
- CX3CL1 is implicated in immunogenic cell death and anticancer immune responses.
Conclusions:
- The effect of CX3CL1 is context-dependent, with excessive levels potentially suppressing immunity.
- CX3CL1-based gene/mRNA therapies, combined with immune checkpoint inhibitors, represent a promising avenue for cancer treatment.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Caspases
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

